MEDIPHARM LABS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.075 CAD | 0.00% |
|
-6.25% | +15.38% |
| Jun. 26 | Transcript : MediPharm Labs Corp. - Shareholder/Analyst Call | |
| Jun. 20 | MediPharm Labs Acquires Rights for Advanced Medical Cannabis Products From Remidose Aerosols | MT |
Evolution of the average Target Price on MediPharm Labs Corp.
Price target over the last 5 years
History of analyst recommendation changes
91e6522a004a785cd0a1d1f84ad.WudhdO4zseuaE2YJ8PRdVgKoZS-bS0vH6zw3J14V3eI.O7ExJ4l569LiJFdLvKE5P2bREGjUBCezgFdBEWhYitUC31Q4uVuJj9J9Jw~5fd86972814e557200b94f09ca92f06f
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.075
CAD
Average target price
0.1
CAD
Spread / Average Target
+33.33%
High Price Target
0.1
CAD
Spread / Highest target
+33.33%
Low Price Target
0.1
CAD
Spread / Lowest Target
+33.33%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
- Stock Market
- Equities
- LABS Stock
- Consensus MediPharm Labs Corp.
